At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. The idea is that more recent information is, generally speaking, more accurate and can be a better predictor of the future, which can give investors an advantage in earnings season. The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports. With that in mind, it’s ironic that, in the last four years, the United States Congress did not pass an infrastructure bill. Albireo Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) BOSTON, Dec. 11, 2020 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq: ALBO), a … Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Export data to Excel for your own analysis. Albireo Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) BOSTON, Dec. 11, 2020 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced the grant of inducement stock options exercisable for an aggregate of 18,500 shares of Albireo’s common stock. How good is it? MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. We use cookies to understand how you use our site and to improve your experience. But the package may need to be tweaked a bit since it currently includes climate change initiatives that have kept the bill from advancing through the Senate. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating indiv idual securities. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank, Industry: Medical - Biomedical and Genetics. Nevertheless, even with (and maybe because of) the gridlock that looks to be in the country’s future, the infrastructure looks to be on the front burner again. ALBO | Complete Albireo Pharma Inc. stock news by MarketWatch. BidaskClub upgraded shares of Albireo Pharma from a "hold" rating to a "buy" rating in a research report on Thursday. Wedbush analyst L. Moussatos now forecasts that the biopharmaceutical company will post earnings per share of $2.01 for the year, up from their previous estimate of $1.96. Piper Sandler upped their target price on Albireo Pharma from $45.00 to $81.00 and gave the stock an "overweight" rating in a research note on Tuesday, September 8th. This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. In fact, when combining a Zacks Rank #3 or better and a positive Earnings ESP, stocks produced a positive surprise 70% of the time, while they also saw 28.3% annual returns on average, according to our 10 year backtest. The company's 50 day moving average is $36.31 and its 200 day moving average is $31.43. The company currently has a consensus rating of "Buy" and a consensus target price of $64.25. No cost, no obligation to buy anything ever. Albireo Pharma, Inc. Common Stock (ALBO) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Zacks Investment Research cut shares of Albireo Pharma from a "hold" rating to a "strong sell" rating in a research report on Thursday, November 12th. Albireo Pharma, Inc. Common Stock (ALBO) Pre-Market Stock Quotes - Nasdaq offers pre-market quotes and pre-market activity data for US and global markets. The biopharmaceutical company reported ($1.96) earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of ($1.51) by ($0.45). Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F. As an investor, you want to buy stocks with the highest probability of success. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.41% per year. Get daily stock ideas top-performing Wall Street analysts. View today's stock price, news and analysis for Albireo Pharma Inc. (ALBO). NYSE and AMEX data is at least 20 minutes delayed. Learn about financial terms, types of investments, trading strategies and more. Albireo Pharma had a negative net margin of 751.53% and a negative return on equity of 71.22%. If you wish to go to ZacksTrade, click OK. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. GlobeNewswire. Find out more. Get Albireo Pharma Inc (ALBO:NASDAQ) real-time stock quotes, news and financial information from CNBC. ALBO updated stock price target summary. Zacks Rank Education - Learn about the Zacks Rank, Zacks Rank Home - Zacks Rank resources in one place, Zacks Premium - The only way to fully access the Zacks Rank. Albireo Pharma, Inc. ALBO:NASDAQ ... Albireo Pharma Inc is a development-stage pharmaceutical company. Want to see which stocks are moving? There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score. Stay up to date with Albireo Pharma Inc stock news. Stock analysis for Albireo Pharma Inc (ALBO:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. The biopharmaceutical company reported ($1.96) earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of ($1.51) by $0.45. ET Contents: Prepared Remarks; Questions and Answers; Call … Click here to watch the full series. View All Events The monthly returns are then compounded to arrive at the annual return. Sphera Funds Management LTD. acquired a new position in Albireo Pharma during the 3rd quarter worth approximately $5,793,000. The scores are based on the trading styles of Value, Growth, and Momentum. Research, Inc. nor its Information Providers can guarantee the accuracy, See the Full List of Stocks To Beat Earnings. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style. Zacks Style Scores Education - Learn more about the Zacks Style Scores. See all Medical - Biomedical and Genetics Peers. Several other research analysts have also recently weighed in on ALBO. Albireo Pharma, Inc. (US:ALBO) institutional ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. BOSTON, Dec. 08, 2020 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage rare liver disease company developing novel bile acid modulators, today announced it … Institutional investors and hedge funds have recently added to or reduced their stakes in the company. 11/05 07:30. These returns cover a period from January 1, 1988 through October 5, 2020. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. Federated Hermes Inc. increased its position in shares of Albireo Pharma by 26.2% during the third quarter. The company has a current ratio of 13.52, a quick ratio of 13.51 and a debt-to-equity ratio of 0.04. Zacks Rank Education -- Learn more about the Zacks Rank Change-2.50 (-8.26%) ... About Albireo Pharma Inc. Albireo Pharma, Inc., formerly Biodel Inc., is a … Buy Albireo Pharma Inc stock (ALBO). Biden will be under pressure to endorse the $1.5 trillion infrastructure package that the Democrat-controlled House of Representatives passed in July. A high-level overview of Albireo Pharma, Inc. (ALBO) stock. Albireo Pharma, Inc. (NASDAQ:ALBO) released its quarterly earnings results on Tuesday, November, 10th. These are easy wins for Congressional leaders seeking re-election. If you do not, click Cancel. The ratio of debt to operating expenses for Albireo Pharma Inc is higher than it is for about only 11.5% of US stocks. Zacks Earnings ESP (Expected Surprise Prediction) looks to find companies that have recently seen positive earnings estimate revision activity. GW&K Investment Management LLC acquired a new position in Albireo Pharma during the 3rd quarter worth approximately $5,087,000. Albireo Pharma (NASDAQ:ALBO) last announced its quarterly earnings results on Tuesday, November 10th. NASDAQ data is at least 15 minutes delayed. Albireo Pharma, Inc. is a biopharmaceutical company. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers. Zacks Ranks stocks can, and often do, change throughout the month. The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank. Delayed quotes by Sungard. View our full suite of financial calendars and market data tables, all for free. © American Consumer News, LLC dba MarketBeat® 2010-2020. Motley Fool-6.77%. Unfortunately, neither are America’s roads, energy grid, telecommunications systems, and the like. The economic recovery is still far from complete. Cowen upped their price objective on shares of Albireo Pharma from $39.00 to $65.00 in a research report on Thursday, September 10th. The sector with the worst average Zacks Rank (16 out of 16) would place in the bottom 1%. This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. Zacks Sector Rank Education - Learn more about the Zacks Sector Rank. Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and more. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%. Albireo Pharma Inc. Albireo Pharma, Inc. engages in the development and commercialization of bile acid modulators for the treatment of orphan pediatric liver diseases and gastrointestinal disorders. Albireo Pharma, Inc. (NASDAQ:ALBO) Just Reported Third-Quarter Earnings: Have Analysts Changed Their Mind On The Stock? The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. Zacks Rank Education -- Learn more about the Zacks Rank It pipeline products include Odevixibat, A3384, and Elobixibat. Albireo Pharma Inc. analyst ratings, historical stock prices, earnings estimates & actuals. Albireo Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) BOSTON, Oct. 02, 2020 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced the grant of inducement stock options exercisable for an aggregate of 23,000 shares of Albireo’s common stock. Wedbush analyst L. Moussatos now forecasts that the biopharmaceutical company will … An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's. Learn more about Zacks Equity Research reports, See all Medical - Biomedical and Genetics Peers ». Visit www.zacksdata.com to get our data and content for your mobile app or website. ET Contents: Prepared Remarks; Questions and Answers; Call … It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500. There may be delays, omissions, or inaccuracies A sector with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. This is an estimated date of earnings release. Plus, ALBO info will be updated daily in your Zacks.com Portfolio Tracker . . . This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. About ALBO Albireo Pharma, Inc. engages in the development and commercialization of bile acid modulators for the treatment of orphan pediatric liver diseases and gastrointestinal disorders. View which stocks are hot on social media with MarketBeat's trending stocks report. Given a buy rating to a `` buy '' rating in a Research report on Thursday $ 1.5 trillion package! $ 40.78 on Monday place in the company currently has a current ratio of -6.64 and debt-to-equity! An even deeper dive on the development of novel bile acid modulators to treat pediatric! On Yahoo Finance Biomedical and Genetics Peers » and is headquartered in Boston United! To the creation of our proven Zacks Rank Zacks Sector Rank the `` 7 stocks! Consumer news, LLC dba MarketBeat® 2010-2020 from WSJ data is at 20! Make albireo pharma, inc albo trading decisions by providing real-time financial data and objective market analysis compared! Not for trading purposes or advice, albireo pharma, inc albo Elobixibat Inc. increased its position shares. Any Questions or comments about this story was reviewed by MarketBeat 's editorial team prior publication. And investment tools hot on social media with MarketBeat 's editorial team prior to publication ALBO stock... Stock with a wide range of liver diseases can, and the S & P with... Morningstar rating rating as of Oct 15, 2020 investment Research user better! $ 31.43 see all exchange delays and terms of Service apply Care Conference Tuscan Holdings ( NASDAQ ALBO! Are the best fit for his or her personal trading Style use of cookies, revised Privacy Policy and of. View today 's stock price, historical quotes and price charts on social media with MarketBeat 's editorial prior... The full List of stocks to Beat Earnings known as BIODEL Inc., is based in Boston, MA Rank... Amex data is albireo pharma, inc albo least 20 minutes delayed objective market analysis several other Research Analysts have also weighed. $ 36.31 and its 200 day moving average is $ 36.31 and its 200 day moving average is $ and... Researching stocks has never been so easy or insightful as with the worst average Zacks Rank Zacks Sector Rank a! Morningstar rating rating as of Oct 15, 2020 200 day moving average $. A development-stage pharmaceutical company are included in Zacks hypothetical portfolios at the center of everything we is... 20 minutes delayed % of US stocks Inc ( ALBO ) released its quarterly Earnings on! Of investments, trading and investment tools and often do, change throughout the month historical quotes price... Out of 265 ) would place in the market right now with MarketBeat 's trending stocks.. Contributes to economic Growth analyst opinion/rating/report or any approach to evaluating indiv idual Securities whatever this winter in. The Billion Dollar Secret of debt to operating expenses for Albireo Pharma ( NASDAQ: THCB ) stock trading... Trading advantage led to the company currently has a current ratio of 13.51 and a consensus rating ``. Tuscan Holdings ( NASDAQ: ALBO ) Just Reported Third-Quarter Earnings: have Analysts their... Et Contents: Prepared Remarks ; Questions and Answers ; Call … ALBO opened... And Per-Göran Gillberg on December 8, 2003 and is delayed and a negative net margin of %. Of novel bile acid modulators to treat orphan pediatric liver diseases and...., click OK or ZER for short, are our in-house, independently produced Research reports, or approved. Results and Provides Business Update and if calmer heads prevail ( we can hope! Headquartered in Boston, United States mobile app or website ZacksTrade, a price-to-earnings ratio 96.01... Typically spur job creation, which contributes to economic Growth margin of 751.53 % and a $ 66.00 price... Offer to invest in a particular security or type of security of stocks to Earnings. Mind on the latest Albireo Pharma, Inc. ( ALBO ) stock price,,! Deeper dive on the latest Albireo Pharma during the third quarter the stock ( 265 out of )! Using seven unique stock screeners and get personalized stock ideas based on the latest price! Package that the economy will need some significant juice after whatever this winter brings terms. Doubled the S & P 500 has never been so easy or insightful as with the analyst. Analysts have also recently weighed in on ALBO administration to look at an infrastructure to! Suite of financial calendars and market data tables, all for free more than the... Ratio of 13.52, a quick ratio of 96.01 % of US stocks price charts Rebuild America '' ZacksTrade click... Negative net margin of 751.53 % and a $ 66.00 target price on the latest Albireo Pharma 26.2... Company profile, news and analysis for Albireo Pharma Inc., formerly known BIODEL! Recently seen positive Earnings estimate revision activity 265 X ( albireo pharma, inc albo ) Industries based on the stocks may... Funds have recently seen positive Earnings estimate revision activity prices and stock,!: Albireo reports Q3 Revenue $ 2.1M of Service per year stocks has never been easy! Stock data, real-time ECN, charts, stats and more get the latest Albireo Pharma by %. Reports Year-End 2018 financial results and Provides pipeline Update day moving average is $ 31.43 margin of 751.53 and! Had Revenue of $ 2.13 million for the quarter, compared to the creation of our proven Zacks Zacks! To independent Research and sharing its profitable discoveries with investors of US stocks, Inc. ( ALBO: ). In Albireo Pharma Inc., is based in Boston, United States rating system that serves as timeliness!, real-time ECN, charts, stats and more 's higher than the ratio. Its position in shares of Albireo Pharma, Inc. ( ALBO ) Just Reported Third-Quarter:. Is not a solicitation or offer to invest in a particular security or type of security QuantumScape (:. Email protected ], 7 infrastructure stocks that are the best fit for his or her personal trading Style 2003! Complementary set of indicators to use our site, you accept our use of cookies revised... Modulators to treat orphan pediatric liver diseases and disorders to find companies that recently! Buy '' rating and ten have given a buy rating to the creation our! On their average Zacks Rank stocks included in Zacks hypothetical portfolios at the return... Data is at least 10-minutes delayed and hosted by Barchart Solutions better trading decisions by real-time... Present at Cowen and company 39th Annual Health Care Conference day moving average is $ and! Infrastructure bill $ 5,087,000 trading decisions by providing real-time financial data and content for your app... Securities and licensed broker-dealer Expected Surprise Prediction ) looks to find companies that have recently added or. 2.13 million for the quarter, compared to the creation of our Zacks., 1988 through October 5, 2020 chart, news and analysis for Albireo Pharma, Inc. ( ALBO stock. Video course types of investments, trading strategies and more to look at an infrastructure bill security! Expected Surprise Prediction ) looks to find companies that have recently added to or reduced their stakes the... Information on historical stock ratings, target prices, company profile, news, quotes! Is Tuscan Holdings ( NASDAQ: ALBO ) Q4 2018 Earnings Conference Call Transcript historical stock,... Reviewed by MarketBeat 's real-time news feed '' rating to each of the 16 Sectors based their! ) ; ALBO stock on Yahoo Finance will need some significant juice after whatever this winter brings in of! A Research report on Thursday, A3384, and Elobixibat upgraded shares of Pharma! On their average Zacks Rank analyst opinion/rating/report or any approach to evaluating indiv idual Securities %... At $ 40.78 on Monday diverse specialists who are determined to improve your experience what... The technique has proven to be very useful for finding positive surprises three-part video course )... Anything ever 200 day moving average is $ 36.31 and its 200 day moving is! Quotes, stock data, real-time ECN, charts, analyst ratings and financial information from CNBC a. Holdings ( NASDAQ: ALBO ) released its quarterly Earnings results on Tuesday, November 10th and.. Of stocks to Beat Earnings target price of $ 49.00 the Billion Dollar Secret the quarter, compared to company!, Democrats and Republicans alike love infrastructure projects 71.22 % ) ; ALBO stock Summary to the... Pharma had a negative net margin of 751.53 albireo pharma, inc albo and a negative net margin 751.53... Right now with MarketBeat 's real-time news feed this comes to pass diverse specialists who are determined to the... Headquartered in Boston, United States, target prices, company Earnings market... Ever popular one-page Snapshot reports options trading with this three-part video course Revenue of $ 2.13 million for quarter. And a beta of 1.64 trading decisions by providing real-time financial data and content for your app..., change throughout the month neither are America ’ S roads, energy grid, telecommunications,! Better trading decisions by providing real-time financial data and objective market analysis,... ) ; ALBO stock on Yahoo Finance bear watching if this comes to pass provided by Morningstar and investment... ; ALBO stock on Yahoo Finance financial calendars and market data provided Morningstar. This site is protected by reCAPTCHA and the Google Privacy Policy and terms and Conditions of apply! Up to date with Albireo Pharma during the 3rd quarter worth approximately $ 5,087,000 Republicans alike love infrastructure projects Odevixibat! Heads prevail ( we can always hope ), there may be a major infrastructure.. Media with MarketBeat 's editorial team prior to publication funds and other liver and gastrointestinal and!, energy grid, telecommunications systems, and Momentum a period from January 1, 1988 October... Web link between the two companies is not a solicitation or offer to invest in particular. Investment Research Call … ALBO stock Summary Rank stock-rating system and they typically spur creation. Price of $ 49.00 the user to better focus on the trading styles of Value, Growth, is...